QQ客服 官方微博 反馈留言

浏览/检索结果: 共7条，第1-7条 帮助 已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Results of the phase IIa study to evaluate the efficacy and safety of rezivertinib (BPI-7711) for the first-line treatment of locally advanced or metastatic EGFR mutation from a phase I 期刊论文 BMC MEDICINE, 2023, 卷号: 21, 期号: 1 作者:  Yuankai Shi;  Jianying Zhou;  Yanqiu Zhao;  Bo Zhu;  Liangming Zhang 收藏  |  浏览/下载：0/0  |  提交时间：2024/05/07 Integrated genomic and DNA methylation analysis of patients with advanced non-small cell lung cancer with brain metastases 期刊论文 MOLECULAR BRAIN, 2021, 卷号: 14 作者:  Xu, Yanjun;  Huang, Zhiyu;  Yu, Xiaoqing;  Chen, Kaiyan;  Fan, Yun 收藏  |  浏览/下载：74/0  |  提交时间：2022/01/25 Brain metastases  Predictive biomarker  DNA methylation  Somatic mutation  Advanced non-small cell lung cancer (advanced NSCLC)   AdvanTIG-302: Anti-TIGIT monoclonal antibody (mAb) ociperlimab (OCI) plus tislelizumab (TIS) versus pembrolizumab (PEM) in programmed death ligand-1 (PD-L1) selected, previously untreated, locally advanced, unresectable or metastatic non-small cell lung cancer (NSCLC). 期刊论文 JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39 作者:  Socinski, Mark A.;  Spira, Alexander I.;  Paz-Ares, Luis G.;  Reck, Martin;  Lu, Shun 收藏  |  浏览/下载：33/0  |  提交时间：2022/01/10 Efficacy and adverse events of five targeted agents in the treatment of advanced or metastatic non-small-cell lung cancer: A network meta-analysis of nine eligible randomized controlled trials involving 5,059 patients 期刊论文 JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 卷号: 234, 期号: 4 作者:  Miao, Ying-Ying;  Liu, Gui-Feng;  Zhang, Shu-Hua;  Li, Xue-Feng;  Yu, Shao-Nan 收藏  |  浏览/下载：13/0  |  提交时间：2019/12/05 advanced or metastatic non-small-cell lung cancer (NSCLC)  adverse events  Bayesian network model  efficacy  randomized controlled trials  targeted agents   Final Overall Survival Results from a Phase III, Randomized, Placebo-Controlled, Parallel-Group Study of Gefitinib Versus Placebo as Maintenance Therapy in Patients with Locally Advanced or Metastatic Non-Small-Cell Lung Cancer (INFORM; C-TONG 08 期刊论文 2015, 卷号: 10, 期号: 4, 页码: 655-664 作者:  Zhao, Hongyun;  Fan, Yun;  Ma, Shenglin;  Song, Xiangqun;  Han, Baohui 收藏  |  浏览/下载：3/0  |  提交时间：2020/01/13 Gefitinib  Maintenance  NSCLC  INFORM  OS   Efficacy and safety of gefitinib or docetaxel in Chinese patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) who had failed previous platinum-based first-line chemotherapy 期刊论文 2011, 卷号: 33, 期号: 5, 页码: 377-80 作者:  Sun Yan;  Wu Yi-long;  Li Long-yun;  Liao Mei-lin;  Jiang Guo-liang 收藏  |  浏览/下载：3/0  |  提交时间：2020/01/13 Pre-planned Subgroup Analyses From the Phase III, Randomised, Placebo-controlled, Parallel-group Study of Gefitinib (G) as Maintenance Therapy in Patients (pts) With Locally Advanced or Metastatic Non-small-cell Lung Cancer (NSCLC) (INFORM; C-TON 会议论文 EUROPEAN JOURNAL OF CANCER, 2011-09-01 作者:  Zhang, L.;  Ma, S. L.;  Song, X. Q.;  Cheng, Y.;  Huang, C. 收藏  |  浏览/下载：1/0  |  提交时间：2020/01/13